 Lexaria has progressed significantly in evidencing that its patented DehydraTECHTM drug delivery technology can sufficiently improve the usable fraction of known antiviral drugs that reach the bloodstream. According to a Newsfile Corp. article, this technology can be applied to rendering treatments for HIVAIDS and other infectious diseases more effective 